Quadratus Lumborum Block Type III Versus Type II Versus Transversus Abdominis Plane Block in Cesarean Section
NCT ID: NCT05950568
Last Updated: 2023-07-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2023-03-24
2023-06-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Quadratus Lumborum Block vs Tranversus Abdominis Plane Block for Cesarean Section
NCT02489851
Quality of Recovery After Quadratus Lumborum Block for Cesarean Section.
NCT03516786
A Comparing Transversalis Fascia Plane Block and Quadratus Lumborum Block for Post-Cesarean Pain Management: Efficacy, Execution Time, and Practicality
NCT06874569
Anterior Quadratus Lumborum Block Versus Erector Spinae Plane Block After Elective Cesarean Section
NCT05254093
Quadratus Lumborum Block Type 2 Versus Posterior Transversus Abdominus Plane Block
NCT04773730
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The quadratus lumborum (QL) muscle block (QLB) is a fascial plane block as local anesthetic (LA) is introduced nearby to the QL muscle to numb the thoracolumbar nerves. QLB is categorized into four types according to drug administration location, I (lateral), II (posterior), III (anterior/transmuscular), and Intravenous, (intramuscular). QLB can effectively decrease both visceral and somatic pain by LA distribution to the thoracic paravertebral space (TPVS), as this block ensures effective pain control from the T7 to L1 dermatomes. QLB is one of the regional techniques that provides the greatest benefit in post-CS pain control, as it is progressively applied in obstetric anesthetic precise to improve analgesic results.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Quadratus lumborum block type II
A 22 gauge needle was positioned between the erector spinae muscle in the thoracolumbar fascia's middle layer
Quadratus lumborum block typen II
A 22 gauge needle was positioned between the quadratus lumborum muscle posterior border and the erector spinae muscle in the thoracolumbar fascia's middle layer
Quadratus lumborum block type III
A 22 gauge needle was positioned between the psoas and quadratus lumborum muscles at the anterior fascia lumbosacral
Quadratus lumborum block III
A 22 gauge needle was positioned between the psoas and quadratus lumborum muscles at the anterior fascia lumbosacral
Transversus abdominis plane block
A 22 gauge needle was positioned between the internal oblique and transversus abdominis muscles
Transversus abdominis plane block
A 22 gauge needle was positioned between the internal oblique and transversus abdominis muscles
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Quadratus lumborum block typen II
A 22 gauge needle was positioned between the quadratus lumborum muscle posterior border and the erector spinae muscle in the thoracolumbar fascia's middle layer
Quadratus lumborum block III
A 22 gauge needle was positioned between the psoas and quadratus lumborum muscles at the anterior fascia lumbosacral
Transversus abdominis plane block
A 22 gauge needle was positioned between the internal oblique and transversus abdominis muscles
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* aged 18 to 40 years old
* presenting for elective Cesarean section
Exclusion Criteria
* weight \< 50kg
* height \< 150 cm
* contraindications for the use of active labor, spinal anesthesia
* recent opiate intake
* hypersensitivity to any used medication
* substantial cardiovascular diseases
* renal diseases
* hepatic, diseases.
18 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The General Authority for Teaching Hospitals and Institutes
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Abeer Ali Elshabacy
Consultant of obstetrics and gynecology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The General Authority for Teaching Hospitals and Institutes
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HB000132
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.